We investigated the effect of long-term treatment with lobeglitazone, a novel thiazolidinedione-based activator of peroxisome proliferator-activated receptor gamma, on adipose tissue (AT), focusing on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback